Drug Insights

The Synapse User's Toolkit: Tips for Searching Propranolol

2 February 2024
2 min read

Propranolol Hydrochloride, a small molecule drug, targets the β-adrenoceptors as an antagonist, exhibiting an assortment of therapeutic effects. This drug is used to treat various conditions, including hypertension, angina pectoris, atrial fibrillation, atrial premature complexes, bradycardia, and tachycardia. AstraZeneca developed Propranolol Hydrochloride, which received approval on August 18th, 1966. Propranolol Hydrochloride works by blocking the sympathetic nervous system's action on the heart and blood vessels, which ultimately results in a reduction in heart rate, blood pressure, and oxygen demand. Although Propranolol Hydrochloride can be effective in managing these conditions, it can also cause side effects such as fatigue, dizziness, and depression, and as such, it should only be taken under the guidance of a healthcare provider. Careful monitoring of patients for any adverse effects is also necessary. Overall, Propranolol Hydrochloride is a useful medication for managing heart-related conditions, but each individual patient's case should be carefully considered before use. Click on the image below to begin the exploration journey of Propranolol through the Synapse database!

图形用户界面, 文本, 应用程序, 电子邮件

描述已自动生成

You can search for the latest pharmaceutical information such as drugs, targets, patents, transactions, clinical results, etc. through the Synapse database. Come and experience it!

图形用户界面, 文本, 应用程序, 聊天或短信

描述已自动生成

EMA Reviews Application for PADCEV® Plus KEYTRUDA® Combo as Initial Therapy for Progressive Bladder Cancer
Latest Hotspot
3 min read
EMA Reviews Application for PADCEV® Plus KEYTRUDA® Combo as Initial Therapy for Progressive Bladder Cancer
2 February 2024
On Jan 26, Pfizer and Astellas Pharma announced that the European Medicines Agency (EMA) has accepted to review a Type II variation application for the combined use of PADCEV® and KEYTRUDA®.
Read →
Unlock the Power of Synapse: A Guide to Searching Hydrochlorothiazide
Drug Insights
2 min read
Unlock the Power of Synapse: A Guide to Searching Hydrochlorothiazide
2 February 2024
Hydrochlorothiazide, a small molecule drug, targets the NCC co-transporter as an inhibitor, exhibiting an assortment of therapeutic effects.
Read →
KEYTRUDA® Boosts DFS in High-Risk Urothelial Carcinoma Post-Surgery
Latest Hotspot
3 min read
KEYTRUDA® Boosts DFS in High-Risk Urothelial Carcinoma Post-Surgery
2 February 2024
KEYTRUDA® (Pembrolizumab) Enhances Disease-Free Survival (DFS) as Adjuvant in High-Risk Urothelial Carcinoma Post-Surgery.
Read →
How to Effectively Search for Tizanidine on Synapse
Drug Insights
2 min read
How to Effectively Search for Tizanidine on Synapse
2 February 2024
Tizanidine Hydrochloride, a minuscule molecule drug, is a potent agonist that targets the ADRA2 receptor with high specificity.
Read →
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.